Please use this identifier to cite or link to this item: http://hdl.handle.net/11452/34832
Title: Concomitant use of corticosteroids at the baseline does not affect the drug survival of abatacept in rheumatoid arthritis
Authors: Koca, Süleyman Serdar
Öz, Burak
Karataş, Ahmet
Can, Gercek
Şenel, Soner
Yazıcı, Ayten
İnanç, Nevsun
Cefle, Ayşe
Ertürk, Zeynep
Akar, Servet
Göker, Berna
Birlik, Merih
Önen, Fatoş
Uludağ Üniversitesi/Tıp Fakültesi/Dahiliye Anabilim Dalı/Romatoloji Bilim Dalı.
Dalkılıç, Ediz
Pehlivan, Yavuz
Yağız, Burcu
AAG-8227-2021
Keywords: Rheumatology
Issue Date: Jun-2018
Publisher: BMJ
Citation: Koca, S. S. vd. (2018). ''Concomitant use of corticosteroids at the baseline does not affect the drug survival of abatacept in rheumatoid arthritis''. Annals of the Rheumatic Diseases, 77(Supplement 2), 597-597.
Description: Bu çalışma, 13-16, Haziran 2018 tarihlerinde Amsterdam[Hollanda]’da düzenlenen Congress of the European-League-Against-Rheumatism (EULAR) Kongresi‘nde bildiri olarak sunulmuştur.
URI: https://doi.org/10.1136/annrheumdis-2018-eular.5819
https://ard.bmj.com/content/77/Suppl_2/597.1
http://hdl.handle.net/11452/34832
ISSN: 0003-4967
1468-2060
Appears in Collections:Web of Science

Files in This Item:
File Description SizeFormat 
Dalkılıç_vd_2018.pdf743.46 kBAdobe PDFThumbnail
View/Open


This item is licensed under a Creative Commons License Creative Commons